FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
UPDATE: Canaccord Genuity Upgrades Acadia Pharmaceuticals (ACAD) to Buy on Risk/Reward Into AdCom
Tweet Send to a Friend
(Updated - March 16, 2022 8:06 AM EDT)
Canaccord Genuity analyst Sumant Kulkami upgraded Acadia Pharmaceuticals (NASDAQ: ACAD) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst Sumant Kulkami upgraded Acadia Pharmaceuticals (NASDAQ: ACAD) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
